8-KThe WireRoutine
Reg FD Disclosure
Filed Nov 28, 2017 · 8y ago · Accession 0001564590-17-024262
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Viking Therapeutics, Inc.
- Ticker
- VKTX
- CIK
- 1607678
- Form type
- 8-K
- Filing date
- Nov 28, 2017
- Report date
- Nov 28, 2017
- Document
- vktx-8k_20171128.htm
- Size
- 65 KB